Source:http://linkedlifedata.com/resource/umls/id/C0677634
MSH: Clotting time of PLASMA mixed with a THROMBIN solution. It is a measure of the conversion of FIBRINOGEN to FIBRIN, which is prolonged by AFIBRINOGENEMIA, abnormal fibrinogen, or the presence of inhibitory substances, e.g., fibrin-fibrinogen degradation products, or HEPARIN. BATROXOBIN, a thrombin-like enzyme unaffected by the presence of heparin, may be used in place of thrombin.,NCI: A measurement of the time it takes a plasma sample to clot after adding the snake venom enzyme batroxobin (reptilase). This procedure can be used to detect deficiencies or abnormalities in fibrinogen and this enzyme is resistant to both endogenous thrombin inhibitors and heparin.,NCI: A measurement of the time it takes a plasma sample to clot after adding the active enzyme thrombin.,NCI: A measurement of the time it takes a plasma sample to clot after adding the active enzyme thrombin. (NCI)